أعرض في EDS

Words (Excluding Tãtle and Authors: 300) Title: Cost-Effectiveness Analysis of Nivolumab for the Treatment of Second-Line Advanced Squamous Non-Small Cell Lung Cancer (Nsclc) in Spain

التفاصيل البيبلوغرافية
العنوان: Words (Excluding Tãtle and Authors: 300) Title: Cost-Effectiveness Analysis of Nivolumab for the Treatment of Second-Line Advanced Squamous Non-Small Cell Lung Cancer (Nsclc) in Spain
المؤلفون: Pilar Garrido, Oyagüez, Jose Manuel Trigo, M Echave, Enriqueta Felip, S Jiménez, P González García, N Ortega-Joaquin
المصدر: Web of Science
بيانات النشر: Elsevier BV, 2016.
سنة النشر: 2016
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Second line, business.industry, Health Policy, Internal medicine, Public Health, Environmental and Occupational Health, medicine, Squamous non-small cell lung cancer, Cost-effectiveness analysis, Nivolumab, business
تدمد: 1098-3015
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d8efcb26ec803016220373f6f22749c
https://doi.org/10.1016/j.jval.2016.09.2210
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....9d8efcb26ec803016220373f6f22749c
قاعدة البيانات: OpenAIRE
الوصف
تدمد:10983015